Klaus A Tiroch
Overview
Explore the profile of Klaus A Tiroch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tiroch K, Sibbing D, Koch W, Roosen-Runge T, Mehilli J, Schomig A, et al.
Am Heart J
. 2010 Sep;
160(3):506-12.
PMID: 20826260
Background: The prodrug clopidogrel requires activation by cytochrome P-450 (CYP) enzymes for its antiplatelet effect. The genes encoding enzymes for clopidogrel activation are polymorphic, leading to reduced or increased function,...
2.
Tiroch K, Byrne R, Kastrati A
Expert Opin Pharmacother
. 2010 May;
11(11):1855-72.
PMID: 20486833
Importance Of The Field: The introduction of percutaneous intervention represented a major milestone in the management of obstructive arterial disease. Restenosis following intervention has been a key limitation of this...
3.
Tiroch K, Matheny M, Resnic F
Am Heart J
. 2010 Jan;
159(1):125-30.
PMID: 20102878
Background: We evaluated the exact quantitative long-term impact of repeated catheterizations, vascular closure devices, and cardiovascular risk factors on the femoral artery after cardiac catheterization. Methods: A total of 2,102...
4.
Tiroch K, Arora N, Matheny M, Liu C, Lee T, Resnic F
Am J Cardiol
. 2008 Nov;
102(11):1473-6.
PMID: 19026298
Retroperitoneal hemorrhage (RPH) is a potentially catastrophic complication after percutaneous coronary intervention (PCI). Previous studies identified female gender, body surface area, and high arterial puncture location as independent risk factors...